Ginkgo Bioworks Holdings, Inc.·4

May 26, 5:04 PM ET

Coen Steven P. 4

4 · Ginkgo Bioworks Holdings, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Ginkgo (DNA) CFO Steven Coen Sells 307 Shares After RSU Vesting

What Happened

  • Steven P. Coen, Chief Financial Officer of Ginkgo Bioworks (DNA), had restricted stock units (RSUs) convert into common shares on May 21, 2026 (two conversion/settlement entries for 587 and 156 shares; total 743 shares). Following the vesting, 307 shares were sold in an open-market transaction on May 22, 2026 at $8.33 per share for total proceeds of $2,559. The filing indicates the sale was to cover tax withholding obligations related to the RSU vesting.

Key Details

  • Transaction dates/prices: RSU conversion recorded 2026-05-21; open-market sale of 307 shares on 2026-05-22 at $8.33 per share (proceeds $2,559).
  • Shares acquired via conversion: 587 and 156 shares (total 743) on 2026-05-21.
  • Shares sold: 307 shares in open market; other converted shares were disposed/withheld as indicated in the filing to satisfy tax obligations.
  • Shares owned after transaction: not specified in this Form 4.
  • Notable footnotes: F1—each RSU = one share on settlement; F2—sale was a "sell to cover" to satisfy tax withholding (not a discretionary trade); F3–F4—describe the RSU vesting schedules underlying the conversions.
  • Filing date: Form 4 filed 2026-05-26; timing appears consistent with standard Form 4 reporting deadlines.

Context

  • The filing reflects RSU settlement and a routine sell-to-cover for taxes rather than a discretionary sale for investment reasons. For retail investors, such tax-related sales are common following vesting and generally do not by themselves signal a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-05-21
Coen Steven P.
See remarks
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-05-21+58750,855 total
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-05-21+15651,011 total
  • Sale

    Class A Common Stock

    [F2]
    2026-05-22$8.33/sh307$2,55950,704 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F3]
    2026-05-215877,057 total
    Class A Common Stock (587 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F4]
    2026-05-211563,443 total
    Class A Common Stock (156 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
  • [F3]The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
  • [F4]The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
Signature
/s/ Karen Tepichin, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    wk-form4_1779829445.xmlPrimary

    FORM 4